Humacyte Announces Planned Marketing Authorization Application for Symvess(R) in Israel
(NASDAQ:HUMA), – Expansion plans are based on requests for product access received from surgeons and hospitals in Israel – – Expansion of Symvess into other territories, including those in Europe and the Middle East, is also planned – DURHAM, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company […]